Skip to main content
. Author manuscript; available in PMC: 2018 Apr 29.
Published in final edited form as: Nature. 2017 Jul 19;547(7664):413–418. doi: 10.1038/nature23270

Extended Data Figure 7. Ptpn2-null tumours have increased effector T cell populations, but no other significant differences in immune infiltrates compared with control tumours were found.

Extended Data Figure 7

a, Representative plots showing the gating strategy for the data shown in Fig. 4a. Populations of interest are gated in blue. b, The number of CD45+ cells per mg of tumour for Ptpn2-null (red) and control (grey) B16 tumours. Data are mean ± s.d. c, Representative plots showing the gating strategy for the quantification of T cell populations from Ptpn2-null and control B16 tumours shown in d. Populations of interest are gated in blue. d, Quantification of effector T cell populations in either Ptpn2-null or control B16 tumours. Data mean ± s.d. Data pooled from two independent experiments with a minimum of eight mice per group.